Showing 1 - 5 results of 5 for search 'Pietro Schino', query time: 1.46s Refine Results
  1. 1
    Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study

    Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study by Nicola Scichilone, Raffaele Antonelli Incalzi, Francesco Blasi, Pietro Schino, Giuseppina Cuttitta, Alessandro Zullo, Alessandra Ori, Giorgio Walter Canonica, on behalf of STORICO study group

    Published 2019-09-01
    Get full text
    Article
  2. 2
    Correction to: Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study

    Correction to: Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study by Nicola Scichilone, Raffaele Antonelli Incalzi, Francesco Blasi, Pietro Schino, Giuseppina Cuttitta, Alessandro Zullo, Alessandra Ori, Giorgio Walter Canonica, on behalf of STORICO study group

    Published 2019-12-01
    Get full text
    Article
  3. 3
    Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study

    Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study by Alessandra Vultaggio, Maria Aliani, Elena Altieri, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Paolo Cameli, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Maria D’Amato, Fausto De Michele, Stefano Del Giacco, Fabiano Di Marco, Francesco Menzella, Girolamo Pelaia, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Marco Benci, Silvia Boarino, Jan Walter Schroeder

    Published 2023-05-01
    Get full text
    Article
  4. 4
    Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis

    Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis by Maria D'Amato, Francesco Menzella, Elena Altieri, Elena Bargagli, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Giorgio Walter Canonica, Giorgio Walter Canonica, Cristiano Caruso, Stefano Centanni, Fausto De Michele, Fabiano Di Marco, Elide Anna Pastorello, Girolamo Pelaia, Paola Rogliani, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Gianenrico Senna, Gianenrico Senna, Alessandra Vultaggio, Alessandra Ori, Lucia Simoni, Silvia Boarino, Gianfranco Vitiello, Maria Aliani, Stefano Del Giacco

    Published 2022-05-01
    Get full text
    Article
  5. 5
    Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis

    Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis by Cristiano Caruso, Paolo Cameli, Elena Altieri, Maria Aliani, Pietro Bracciale, Luisa Brussino, Maria Filomena Caiaffa, Giorgio Walter Canonica, Giorgio Walter Canonica, Stefano Centanni, Maria D’Amato, Stefano Del Giacco, Fausto De Michele, Elide Anna Pastorello, Girolamo Pelaia, Paola Rogliani, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Marco Caminati, Marco Caminati, Alessandra Vultaggio, Alessandro Zullo, Sara Rizzoli, Silvia Boarino, Gianfranco Vitiello, Francesco Menzella, Fabiano Di Marco

    Published 2022-09-01
    Get full text
    Article

Search Tools: